Infrastructure Capital Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,681
Closed -$272K 107
2022
Q4
$272K Sell
1,681
-2,706
-62% -$415K 0.04% 77
2022
Q3
$589K Buy
4,387
+2,446
+126% +$351K 0.01% 43
2022
Q2
$297K Buy
+1,941
New +$297K 0.03% 69
2021
Q4
Sell
-3,101
Closed -$337K 35
2021
Q3
$337K Buy
+3,101
New +$354K 0.05% 45
2021
Q2
Sell
-3,002
Closed -$325K 64
2021
Q1
$325K Buy
+3,002
New +$321K 0.09% 44
2020
Q4
Sell
-2,000
Closed -$175K 54
2020
Q3
$175K Buy
+2,000
New +$188K 0.1% 47

Other funds holding ABBV

Infrastructure Capital Advisors's ABBV Position: Q1 2023 in Review

Infrastructure Capital Advisors sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 1,681 shares — an estimated $272K sold.

Infrastructure Capital Advisors first reported a position in ABBV in Q3 2020 and held it in 6 quarters. The position peaked at $589K in Q3 2022. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • Infrastructure Capital Advisors reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
  • Infrastructure Capital Advisors sold 1,681 AbbVie shares in Q1 2023, an estimated $272K.
  • Infrastructure Capital Advisors first reported a position in AbbVie in Q3 2020 and held it in 6 quarters.
  • Infrastructure Capital Advisors's AbbVie position peaked at $589K in Q3 2022.
  • 3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Infrastructure Capital Advisors's 13F filing for Q1 2023, filed 15 May 2023.